Series date: 
04/01/2019 - 12:00pm EDT to 09/30/2019 - 1:00pm EDT

A multidisciplinary team approach to care is fostered through peer-to-peer discussion and collaboration.  The team diagnosis and treatment, includes radiological, pathological findings and immunohistochemical testing, bridges these gaps across the continuum of care in order to enhance the overall quality of patient-centered GU care.

Medical Oncologists, Radiation Oncologists, General Surgeons, Pathologists, Pharmacists, Nurses, Respiratory Therapists (personal growth), Patient Care Facilitators and all Personnel involved in the care of the endocrine cancer patient.

  • Implement optimal course of treatment for endocrine cancer patients.
  • Utilize multiple disciplinary approaches to diagnosis and treatment options, including radiological findings.
  • Determine cancer staging using various modalities of endocrine cancers.
  • Promote a multidisciplinary team approach by bridging gas across the continuum of care in order to enhance the overall quality of patient-centered endocrine cancer care.


MODERATOR: Neeta Erinjeri, M.D.  

CORE GROUP OF CONTRIBUTORS: Surgical Oncologists: Neeta Erinjeri, M.D., Robert Udelsman, M.D., Geoffrey Young, M.D. Medical Oncologist: Guilherme Rabinowits, MD Radiation Oncologist: Noah Kalman, M.D. Pathologists: Edwin Gould, M.D., Rajshri Shah, M.D., Douglas Reale, M.D., Daniel Rubin, M.D Radiologist: Surya Chundru, M.D., Jason Extein, M.D., Prasuna Inampudi, M.D., Ann Podrasky, Hao Vuong, M.D, Endocrinologists: Claudio De Prisco, M.D., Pascual De Santis, M.D., Diane Krieger, M.D., Lara Paraskos, M.D. Julio Pita, M.D. 
Physician moderators take responsibility for facilitating the discussion and ensuring that conversations are evidenced-based and do not promote commercial interests.  They are also responsible for disclosing when off-label treatment approaches have been addressed.

Non-faculty contributors and others involved in the planning, development, and editing/review of the content have no relevant financial relationships to disclose.

Disclosure Policy and Disclaimer

Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.    

Baptist Health South Florida designates these live activities for a maximum of 1 AMA PRA Category 1 Credit™ each. Physicians should claim only the credit commensurate with the extent of their participation in the activity.  

These activities have been approved for 1 credit hour, CE Broker Course #20-717980 by the Florida Boards of Medicine and Osteopathic Medicine.


Series location: 
Miami Cancer Institute
MCI Conference Room 1N612
Miami, FL 33176
United States


Session Date
Endocrine Tumor Board 09/20/2019 - 12:00pm to 1:00pm EDT